Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Toxic”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableStudy completedNCT00564642
What this trial is testing

Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity

Who this might be right for
HepatitisTuberculosis
National Research Institute of Tuberculosis and Lung Disease, Iran 60
Not applicableUnknownNCT01273142
What this trial is testing

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

Who this might be right for
HIV InfectionsLiver ToxicityHepatitis Co-infection
Henan Provincial People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01548690
What this trial is testing

Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury

Who this might be right for
Acute Liver FailureAcute Liver Injury
William Lee 47
Not applicableStudy completedNCT03423641
What this trial is testing

An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Kaiser Permanente 33,808
Large-scale testing (Phase 3)Study completedNCT02182167
What this trial is testing

A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis

Who this might be right for
Drug-Induced Liver Injury
University of Cape Town 102
Not applicableStudy completedNCT03071133
What this trial is testing

Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 344
Early research (Phase 1)UnknownNCT00960167
What this trial is testing

A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 20
Post-approval studies (Phase 4)Ended earlyNCT02479880
What this trial is testing

Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Gilead Sciences 30
Not applicableUnknownNCT04595734
What this trial is testing

Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.

Who this might be right for
Lung Cancer Stage IVLung Cancer, Non-small CellHepatitis
Western Sydney Local Health District 500
Not applicableStudy completedNCT03480529
What this trial is testing

Monitoring the IMmUological TOXicity of Drugs

Who this might be right for
ArthritisSystemic Lupus ErythematosusRheumatoid Arthritis+2 more
Groupe Hospitalier Pitie-Salpetriere 662
Post-approval studies (Phase 4)UnknownNCT01141322
What this trial is testing

Cholestatic Drug-induced Liver Injury

Who this might be right for
Hepatitis, Toxic
Taipei Veterans General Hospital, Taiwan 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619898
What this trial is testing

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

Who this might be right for
ColitisHepatitisMelanoma (Skin Cancer)
Therakos LLC 112
Not applicableUnknownNCT05563961
What this trial is testing

A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers

Who this might be right for
HepatitisPharmacology
Sinew Pharma Inc. 48
Post-approval studies (Phase 4)UnknownNCT06484530
What this trial is testing

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

Who this might be right for
Tuberculosis (TB)Isoniazid ToxicityRifampicin Toxicity+6 more
Mahidol University 116
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80